TrialBlood2026

Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial.

Davide Matino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.